gsk201009106k3.htm
FORM 6-K
 
 
SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549
 
 
Report of Foreign Issuer
 
 
Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934
 
 
 
For period ending September 2010
 
GlaxoSmithKline plc
(Name of registrant)


 
 
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)


 
 
Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F


 
 
Form 20-F x     Form 40-F

 
--

 
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.


 
 
Yes      No x
--

 
 
 
 
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
 
 
I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary shares at a price of £12.71 per Ordinary share on 9 September 2010 through the Company's Share Reward Plan ("the Plan"):
 
Mr A P Witty
Acquisition of 10 Ordinary shares under the partnership element of the Plan (personal contribution)
   
 
Acquisition of 10 Ordinary shares under the matching element of the Plan (Company contribution)
   
Mr J S Heslop
Acquisition of 10 Ordinary shares under the partnership element of the Plan (personal contribution)
   
 
Acquisition of 10 Ordinary shares under the matching element of the Plan (Company contribution)
   
Mr S M Bicknell
Acquisition of 10 Ordinary shares under the partnership element of the Plan (personal contribution)
   
 
Acquisition of 10 Ordinary shares under the matching element of the Plan (Company contribution)
   
Mr E J Gray
Acquisition of 10 Ordinary shares under the partnership element of the Plan (personal contribution)
   
 
Acquisition of 10 Ordinary shares under the matching element of the Plan (Company contribution)
   
Mr S A Hussain
Acquisition of 10 Ordinary shares under the partnership element of the Plan (personal contribution)
   
 
Acquisition of 10 Ordinary shares under the matching element of the Plan (Company contribution)
   
   
Mr D S Redfern
Acquisition of 10 Ordinary shares under the partnership element of the Plan (personal contribution)
   
 
Acquisition of 10 Ordinary shares under the matching element of the Plan (Company contribution)
   
Ms C Thomas
Acquisition of 10 Ordinary shares under the partnership element of the Plan (personal contribution)
   
 
Acquisition of 10 Ordinary shares under the matching element of the Plan (Company contribution)
   
Mr P J T Vallance
Acquisition of 10 Ordinary shares under the matching element of the Plan (Company contribution)
   
 
Acquisition of 10 Ordinary shares under the partnership element of the Plan (personal contribution)
 
The Company and the above-mentioned persons were advised of this information on 10 September 2010.
 
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
 
 
V A Whyte
Deputy Company Secretary
 
 
10 September 2010


 
 

 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.



 
 
GlaxoSmithKline plc
(Registrant)


Date: September 10, 2010
 
 
By: VICTORIA WHYTE
------------------
 
 
Victoria Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc